Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients

Rheumatology

Volumn 47, Issue 1, 2008, Pages 41-44

  Tsukahara, S ^a   Shinozaki, M ^a   Ikari, K ^a   Mochizuki, T ^a   Inoue, E ^a   Tomatsu, T ^a   Hara, M ^a   Yamanaka, H ^a   Kamatani, N ^a   Momohara, S ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Association; Gene; IORRA; MMP 3; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; DNA; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; STROMELYSIN;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; ENZYME SYNTHESIS; FEMALE; FLUORESCENCE ANALYSIS; GENE DELETION; GENE INSERTION; GENE TARGETING; GENOTYPE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JAPANESE; JOINT DESTRUCTION; JOINT RADIOGRAPHY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTH STATUS; HUMANS; JOINTS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 37349101050     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem312     Document Type: Article

References (16)

1. Okada Y. Proteinases and matrix degeneration. In: Harris ED, Budd RC, Firestein GS et al., eds. Kelley's textbook of rheumatology, 7th edn. Philadelphia: Elsevier Saunders, 2005:63-81.
2. Yamanaka H, Matsuda Y, Tanaka M et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852-8.
3. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996;271:13055-60.
4. Constantin A, Lauwers-Cances V, Navaux F et al. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum 2002;46:1754-462.
5. Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH. Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 2004,5:147-9.
6. Tanaka E, Saito A, Kamitsuji S et al. Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set. Arthritis Rheum 2005;53:864-71.
7. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
8. Brownstein MJ, Carpten JD, Smith JR. Modulation of non-templated nucleotide addition by Taq DNA polymerase: Primer modifications that facilitate genotyping. Biotechniques 1996;20:1004-6-1008-10.
9. Obata K, Iwata K, Okada Y et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
10. Matsuda Y, Singh G, Yamanaka H et al. Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum 2003;49:784-8.
11. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA. van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
12. van der Heijde D. How to read radiographs according to the Sharp/van der Haijde method. J Rheumatol 1999;26:743-5.
13. Dörr S, Lechtenbohmer N, Rau R et al. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther 2004;6:199-207.
14. Iwamoto T, Ikari K, Nakamura T et al. Association between PADI4 and rheumatoid arthritis: A meta-analysis. Rheumatology 2006;45:804-7.
15. de Vries N, Tak PP. Possible role of shared epitope status in the relationship between matrix metalloproteinase 3 genotype and radiographic progression of rheumatoid arthritis: Comment on the article by Constantin et al. Arthritis Rheum 2003;48:1162-3, author reply 3-4.
16. MacGregor AJ, Snieder H, Rigby AS et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-7.